PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Science 2.0 / ION Publications, LLC

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Scientific Blogging Names David Houle As Strategic Advisor - David Houle, media executive responsible for branding MTV, VH1 and CNN Headline News, has joined Science 2.0 start-up ScientificBlogging.com as a strategic advisor to handle marketing and corporate communications
Scientific Blogging Names David Houle As Strategic Advisor

 

NewswireToday - /newswire/ - Folsom, CA, United States, 2007/06/06 - David Houle, media executive responsible for branding MTV, VH1 and CNN Headline News, has joined Science 2.0 start-up ScientificBlogging.com as a strategic advisor to handle marketing and corporate communications.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

ScientificBlogging.com has announced that media veteran David Houle has joined the company as a Strategic Advisor. He'll be responsible for guiding the company in its agreements with various mainstream news outlets and the company's marketing efforts.

"We couldn't be more thrilled to have an industry leader who helped establish major brands like MTV, VH1 and CNN Headline News during their formative years," said CEO Hank Campbell. "Since we went into private beta in early February we've had a terrific response and hundreds of thousands of people have read our articles. As we move into a public beta, David's help will be invaluable in insuring that we make the right decisions about who we team up with while keeping the vision and culture that has made us successful so far."

"When I saw a news release about the private beta, I was very intrigued and signed up" said Houle. "I pride myself on having a good eye for interesting concepts and this kind of Science 2.0 site, where featured scientists write original articles and science students and professors host their blogs and get paid to write about science, struck me as a real winner.

"The explosive growth of Web 2.0 and blogging has created a lot of content but ScientificBlogging.com has carved out a place for high-level and intellectually stimulating discourse. The community has gone from opening its doors to over 150,000 readers per month in just its third month of private beta. I am excited to help that grow as it goes into its next stages of development."

ScientificBlogging.com is a new, open science community that hosts columns written by world-class scientists, science writers, science journalists, students and professors in physical sciences, earth sciences, biology, medicine, neuroscience and culture.

Later this month, ScientificBlogging.com will open up a public beta period. Science writers are encouraged to visit the home page and create an account.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Science 2.0 / ION Publications, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Scientific Blogging Names David Houle As Strategic Advisor

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Hank Campbell - IONPublications.com 
408-836-6819 hank[.]scientificblogging.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Science 2.0 / ION Publications, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Science 2.0 / ION Publications, LLC / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)